Biosimilar Purification with Ion Exchange and Mixed-Mode Resins
Bioradiations Staff
February 12, 2020
| Presented by: | Randy Drevland, PhD, Senior Applications Scientist |
View on demand
Purification processes constitute more than half of the development costs for a biosimilar. Dr. Drevland presents a viable alternative workflow for the development of a HUMIRA-like biosimilar using IEX and mixed-mode resins.
Watch Webinar
